Therapeutic TVs for Crossing Barriers in the Brain
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01AG023084, R01NS090904, R01NS034467, R01AG039452, 1R01NS100459, 5P01AG052350, 5P50AG005142)
- Alzheimer’s Association (509279)
- Cure Alzheimer’s Fund
- Foundation Leducq (16 CVD 05)
- NIH (R01AG061288, R01NS110687, R03AG063287, R21AG066090)
- BrightFocus Foundation
This publication has 12 references indexed in Scilit:
- Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysScience Translational Medicine, 2020
- Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in miceScience Translational Medicine, 2020
- Adeno-associated virus vector as a platform for gene therapy deliveryNature Reviews Drug Discovery, 2019
- Blood-Brain Barrier: From Physiology to Disease and BackPhysiological Reviews, 2019
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disordersNature Reviews Neurology, 2018
- Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic AntibodiesNeuron, 2016
- Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearanceNature Neuroscience, 2015
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primatesScience Translational Medicine, 2014
- Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular ShuttleNeuron, 2014
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis TargetScience Translational Medicine, 2011